A new research has found that the human papillomavirus (HPV) vaccine, which protects against cervical cancer in women, reduced the risk of developing the cancer by 62 per cent in women between the ages of 14 and 16.
- The HPV vaccine reduced the risk by 34 per cent in women who were aged 16-18 years when they were offered the jab.
- Human papillomavirus (HPV) is a type of virus, of which there are more than 100 types. The National Cancer Institute (NCI) notes that more than 40 types of HPV are spread through direct sexual contact. Out of these 40, two cause genital warts, while about a dozen of HPV cause different types of cancer including cervical, anal, oropharyngeal, penile, vulvar and vaginal.
- The paper was published in the journal Lancet and looked at all cervical cancers diagnosed in England in women aged between 20 and 64 years, between January 2006 and June 2019.
(Source: Indian Express)
GS TIMES IAS PRELIMS 2022 CURRENT AFFAIRS BASICS DAILY ONLINE TEST SERIES: HINDI AND ENGLISH
CLICK HERE DAILY CURRENT AFFAIRS QUIZ FOR STATE CIVIL SERVICES
